The treatment of atrial fibrillation is perceived to be complex due to its varied clinical presentations and numerous potential therapeutic options. Our article aims to provide the physician with a framework of basic principles with which to assess and treat patients with atrial fibrillation who present acutely.
[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Prystowsky EN. Management of atrial fibrillation: therapeutic options and clinical decisions. Am J Cardiol 2000; 85: 3D-11D.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke. The Framingham Study. Stroke 1991; 22: 983-988.
3. Kannel WB, Abbott RD, Savage DD, et al; The epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018-1022.
4. Furberg CD, Psaty BM, Manolio TA, et al; Prevalence of atrial fibrillation in elderly subjects(The cardiovascular health study). Am J Cardiol 1994; 74: 236-241.
5. Narayan SM, Cain ME, Smith JM. Atrial fibrillation. Lancet 1997; 350: 943-950.
6. Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. British Heart J 1972; 34: 520-525.
7. Wijffels MC, Kirchhof CJ, Dorland R, et al; Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circ 1995; 92: 1954-1968.
8. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2001; 38: 1231-65.
9. Lau CP, Leung WH, Wong CK, et al; Haemodynamics of induced atrial fibrillation: a comparative assessment with sinus rhythm, atrial and ventricular pacing. Eur Heart J 1990; 11: 219-224.
10. Prystowsky EN, Katz A. Atrial fibrillation. In: Topol ES, editor. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven, 1998; 1661-1693.
11. Al-Saady N. M., Sopher M. Prothrombotic markers in atrial fibrillation: what is new? Eur Heart J 2001; 21: 1635-1639.
12. Manning WJ, Leeman DE, Gotch PJ, et al; Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989; 13: 617-623.
13. Miller VT, Rothrock JF, Pearce LA, et al; Ischaemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke prevention in atrial fibrillation investigators. Neurology 1993; 43: 32-36.
14. Bougousslavsky J, Van Melle G, Regli F, et al; Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: the Lausanne Strike registry. Neurology 1990; 40: 1046-1050.
15. Go AS, Hylek EM, Phillips KA, et al; Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circ 2000; 102: 11-13.
16. Duytschaever M, Haerynck F, Tavernier R, et al; Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation. PACE 1998; 21: 284-287.
17. Stroke prevention in atrial fibrillation investigators. Predictors of thromboembolism in atrial fibrillation ii. Echocardiographic features of patients at risk. Ann Intern Med 1992; 116: 6-12.
18. Aronow WS. Management of the older person with atrial fibrillation. J Am Geriatr Soc 1999; 47: 740-748.
19. Dell’Orfano JT, Patel H, Wolbrette DL, et al; Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care. Am J Cardiol 1999; 83: 788-790.
20. Danias PG, Caulfield TA, Weigner MJ, et al; Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 1998; 31: 588-592.
21. Klein EA. Assessment of cardioversion using trasoesophageal echocardiography (TEE) multicentre study (ACCUTE I ): clinical outcomes at eight weeks. J Am Coll Cardiol 2000; 36: 324.
22. Peters NS, Schilling RJ, Kanagaratnam P, et al; Atrial fibrillation: strategies to control, combat and cure. Lancet 2002; 359: 593-603.
23. Jung F, DiMarco JP. Treatment strategies for atrial fibrillation. Am J Med 1998; 104: 272-286.
24. Nichol G, McAlister F, Pham B, et al; Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002; 87: 535-543.
25. Skanes AC, Krahn AD, Yee R, et al; Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. J Am Coll Cardiol 2001; 38: 167-172.
26. Cannom DS. Atrial Fibrillation: nonpharmacological approaches. Am J Cardiol 2000; 85: 25D-35D.
27. Hart RG, Pearce LA, Rothbart RM, et al; Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke prevention in atrial fibrillation investigators. J Am Coll Cardiol 2000; 35: 183-187.
28. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised control trials. Arch Intern Med 1994; 154: 1449-1457.
29. Camm AJ. Atrial fibrillation: is there a role for low-molecular weight heparin? Clin Cardiol 2001; 24 (Suppl I): I15-19.